MY ACCOUNT | NEWSLETTER |

Pedigree awards $100K to shelters


The Pedigree Foundation and Pedigree’s Essential Support Dogs program will award a total of $100,000 in grants to 10 organizations and shelters across the country. The awardees were chosen based on their efforts to eradicate pet homelessness and keep pets with their families during difficult times.

Grant monies were given to groups that help to assist pet owners who have immediate need for boarding, fostering, pet food, or deposits for housing that allows pets. In addition, groups that help families who need help with pet medical expenses could receive funding. 

“We know how much people have turned to their pets for unconditional love and support over the past few years and through the Pedigree brand's Essential Support Dogs program and its donation to support these grants, shelters across the country can continue to keep people and pets together through challenging times,” said Kimberly Wise, president of Pedigree Foundation. “We're inspired by the work shelters are doing to drive change in their communities and help deserving dogs find loving homes. Now more than ever, shelters need our support as they are at capacity and are unable to take more dogs under their care. We encourage people to adopt, foster, volunteer or donate to your local shelter to help continue to drive this change and end pet homelessness.”

Recipients of the grants included Arizona Humane Society, Berkeley Humane, Dallas Pets Alive!, Humane Indiana, Rockbridge Animal Alliance, Seattle Humane, and others. Pedigree Foundation will also pay an additional $2.5 million for financial assistance and food assistance that allows pets to stay with their families. 

Pedigree Foundation is the independent 501(c)(3) non-profit organization portion of the Pedigree brand, which is owned by Mars Incorporated. 

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Penn Vet Announces Interim Leadership for the Department of Clinical Sciences and Advanced Medicine, and Ryan Hospital

Like0
Dislike0

Parnell Launches nixiFLOR® - First FDA-Approved Generic Florfenicol + Flunixin Combination for BRD

Like0
Dislike0

Comparison of two host cell range variants of feline immunodeficiency virus

Like0
Dislike0

Canine babesiosis: a perspective on clinical complications, biomarkers, and treatment

Like0
Dislike0

The use of growth promoters in swine nutrition: Problems and perspectives concerning public health and swine production

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top